14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 4594.T
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

BrightPath Biotherapeutics Co.,Ltd. stock price ended at JP¥55.00 on Friday, after losing 0%.
(Updated on Jun 21, 2024)

Sell candidate since Jun 19, 2024 Loss -9.84% PDF

No changes to the price of BrightPath Biotherapeutics Co.,Ltd. stock on the last trading day (Friday, 21st Jun 2024). During the last trading day the stock fluctuated 7.27% from a day low at JP¥55.00 to a day high of JP¥59.00. The price has fallen in 5 of the last 10 days and is down by -12.7% for this period.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at JP¥53.77 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -4.90% during the next 3 months and, with a 90% probability hold a price between JP¥51.14 and JP¥60.71 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

4594.T Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 20, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BrightPath Biotherapeutics Co.,Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at JP¥60.57 and JP¥59.51. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days.

Support, Risk & Stop-loss for BrightPath Biotherapeutics Co.,Ltd. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved JP¥4.00 between high and low, or 7.27%. For the last week, the stock has had daily average volatility of 5.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (4594.T) For The Upcoming Trading Day Of Monday 24th

For the upcoming trading day on Monday, 24th we expect BrightPath Biotherapeutics Co.,Ltd. to open at JP¥56.33, and during the day (based on 14 day Average True Range), to move between JP¥51.86 and JP¥58.14, which gives a possible trading interval of +/-JP¥3.14 (+/-5.71%) up or down from last closing price. If BrightPath Biotherapeutics Co.,Ltd. takes out the full calculated possible swing range there will be an estimated 11.42% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ JP¥59.00, some JP¥4.00 (7.27%) from the current price of JP¥55.00, our system finds the risk reward not very attractive.

Is BrightPath Biotherapeutics Co.,Ltd. stock A Buy?

BrightPath Biotherapeutics Co.,Ltd. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.753 Sell Candidate Unchanged

Predicted Opening Price for BrightPath Biotherapeutics Co.,Ltd. of Monday, June 24, 2024

Fair opening price June 24, 2024 Current price
JP¥56.33 ( 2.42%) JP¥55.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 4594.T

Fibonacci Support & Resistance Levels

Level Price
R3 60.33 9.70%
R2 58.81 6.92%
R1 57.86 5.20%
Price 55.00
S1 54.81 -0.354%
S2 53.86 -2.07%
S3 52.33 -4.85%

Accumulated Volume Support & Resistance Levels

Level Price
R3 64.00 16.36%
R2 62.00 12.73%
R1 59.00 7.27%
Price 55.00
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for BrightPath Biotherapeutics Co.,Ltd. Stock and on which exchange is it traded?
The symbol for BrightPath Biotherapeutics Co.,Ltd. is 4594.T and it is traded on the TYO (Tokyo Stock Exchange).

Should I buy or sell BrightPath Biotherapeutics Co.,Ltd. Stock?
BrightPath Biotherapeutics Co.,Ltd. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy BrightPath Biotherapeutics Co.,Ltd. Stock?
BrightPath Biotherapeutics Co.,Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BrightPath Biotherapeutics Co.,Ltd. Stock.

What's the current price of BrightPath Biotherapeutics Co.,Ltd. Stock?
As of the end of day on the Jun 21, 2024, the price of an BrightPath Biotherapeutics Co.,Ltd. (4594.T) share was JP¥55.00.

What is the 52-week high and low for BrightPath Biotherapeutics Co.,Ltd. Stock?
The 52-week high for BrightPath Biotherapeutics Co.,Ltd. Stock is JP¥148.00 and the 52-week low is JP¥53.00.

What is the market capitalization of BrightPath Biotherapeutics Co.,Ltd. Stock?
As of the Jun 21, 2024, the market capitalization of BrightPath Biotherapeutics Co.,Ltd. is 4.327B.

When is the next earnings date for BrightPath Biotherapeutics Co.,Ltd.?
The upcoming earnings date for BrightPath Biotherapeutics Co.,Ltd. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About BrightPath Biotherapeutics Co.,Ltd.

BrightPath Biotherapeutics Co.Ltd. BrightPath Biotherapeutics Co., Ltd. develops cancer immunotherapy drugs. The company is developing GRN-1201 that is in Phase II clinical study for the treatment of non-small cell lung cancer, as well as in Phase I clinical study to treat melanoma. It also develops BP1101, a neoantigen vaccine; BP1209, a platform of personalized neoantigen cancer vaccines; and BP1401, an agonist for toll-like receptor 9. In addition, the company offers induced pl... 4594.T Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT